Celltrion Corona 19 antibody treatment approved for use except for’general mild patients’… Domestic No. 1 (general)
Celltrion Corona Treatment Restrictions on Target Administration… Narrowing the width of mild patients
Ministry of Food and Drug Safety’s Central Pharmaceutical Affairs Commission “Recommendation for use of celltrion antibody therapy for moderate and high-risk patients with mild symptoms”: Dong-A Science
“Celltrion corona treatment, recommended for use only in moderate and high risk groups other than mild”… Ministry of Food and Drug Safety Phase 2 Consultation Results (General)
Expert Advisory Group “Rekirona State Needs to Confirm Reduction of Severe Morbidity in Mild and Moderate Certificates”